Individuals with obesity and bad cholesterol levels are more likely to die from cardiovascular disease than people who do not suffer from it, warns a new study. Having diabetes or high blood pressure worsens the risk, said professor Ki-Chul Sung from Kangbuk Samsung Hospital, South Korea.
"People with metabolic disorders had a 1.6-fold-increase in cardiovascular mortality, compared to those who do not have any such disorder," he said.
Patients With Psychosis are at an Increased Risk of Heart Diseases and Obesity
The high levels of cardiovascular risk shown in the study indicate the urgent need for physical activity for those with severe mental illnesses.
Advertisement
The risk factors include abdominal obesity, high level of fats (triglycerides) in the blood, elevated blood pressure, high fasting blood sugar and reduced high-density lipoprotein (HDL) or good cholesterol levels.
For the study, the team examined the records of 155,971 people between 2002 and 2009.
The researchers measured mortality among the subjects by fetching death records from the National Statistical Office of Korea.
![Childhood Cancer Survivors Treated With Cranial Radiation Linked to Obesity Risk]( "Childhood Cancer Survivors Treated With Cranial Radiation Linked to Obesity Risk")
For certain childhood cancer survivors, effective counseling and weight loss interventions are necessary activities to maximize treatment outcomes.
Among the subjects, 12.6% had metabolic syndrome at the time of the screening.
The analysis showed that people with metabolic syndrome faced a greater risk of death from cardiovascular disease than their counterparts.
However, this difference disappeared when people with diabetes or high blood pressure were excluded from the analysis.
"The analysis tells that diabetes and high blood pressure are significant factors that elevate the risk of death from cardiovascular disease among people with metabolic syndrome," noted professor Eun-Jung Rhee from Sungkyunkwan University.
"Younger people having metabolic syndrome should be aware of the risk, particularly those who have diabetes and high blood pressure," he added.
The study was published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism.
Source: IANS
The researchers measured mortality among the subjects by fetching death records from the National Statistical Office of Korea.
Childhood Cancer Survivors Treated With Cranial Radiation Linked to Obesity Risk
For certain childhood cancer survivors, effective counseling and weight loss interventions are necessary activities to maximize treatment outcomes.
Advertisement
Among the subjects, 12.6% had metabolic syndrome at the time of the screening.
The analysis showed that people with metabolic syndrome faced a greater risk of death from cardiovascular disease than their counterparts.
However, this difference disappeared when people with diabetes or high blood pressure were excluded from the analysis.
"The analysis tells that diabetes and high blood pressure are significant factors that elevate the risk of death from cardiovascular disease among people with metabolic syndrome," noted professor Eun-Jung Rhee from Sungkyunkwan University.
"Younger people having metabolic syndrome should be aware of the risk, particularly those who have diabetes and high blood pressure," he added.
The study was published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism.
Source: IANS
Impaired Action of Hunger Hormone Leptin May Not Be the Culprit Behind Obesity
The hormone leptin is produced when we are well fed, indicating the brain that the body has met the energy needs, giving us a feeling of fullness.
Advertisement
 Plymouth Symposium Could Have Ramifications for Tackling Obesity WorldwideBy bringing together such a spectrum of experts, it is possible to capture the series of challenges faced by everyone in the field of obesity care and study. | Advertisement
|
Advertisement
Recommended Reading
Latest Obesity News
Researchers examine the role of unknown protein NOTCH2-associated receptor2 (MINAR2) in obesity and diabetes using generated Minar2 knockout (KO) mice.
Study reports that body contouring after bariatric surgery does not contribute to long-term weight loss in patients with massive weight loss.
Recently FDA-approved drug semaglutide has proven as a highly effective anti-obesity medication showcasing remarkable weight loss benefits.
Gut bacteria profile and abundance in toddlers can serve as a predictive factor for their body mass index (BMI) at age 5, irrespective of premature birth status.
Obese individuals were found to have weaker appetite regulation, with factors that inhibit eating behavior.